Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Cash & Current Investments: 2019-2022

Historic Cash & Current Investments for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to $326.4 million.

  • ADC Therapeutics' Cash & Current Investments rose 81401.60% to $310.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.3 billion, marking a year-over-year increase of 176.85%. This contributed to the annual value of $326.4 million for FY2022, which is 30.03% down from last year.
  • Latest data reveals that ADC Therapeutics reported Cash & Current Investments of $326.4 million as of FY2022, which was down 30.03% from $466.5 million recorded in FY2021.
  • ADC Therapeutics' Cash & Current Investments' 5-year high stood at $466.5 million during FY2021, with a 5-year trough of $115.6 million in FY2019.
  • In the last 2 years, ADC Therapeutics' Cash & Current Investments had a median value of $396.5 million in 2021 and averaged $396.5 million.
  • Data for ADC Therapeutics' Cash & Current Investments shows a maximum YoY slumped of 30.03% (in 2022) over the last 5 years.
  • ADC Therapeutics' Cash & Current Investments (Yearly) stood at $115.6 million in 2019, then reached $466.5 million in 2021, then tumbled by 30.03% to $326.4 million in 2022.